DK1021183T3 - En kombination af en selektiv 5-HT 1A-antagonist og en selektiv h5-HT 1B-antagonist eller partiel antagonist - Google Patents

En kombination af en selektiv 5-HT 1A-antagonist og en selektiv h5-HT 1B-antagonist eller partiel antagonist

Info

Publication number
DK1021183T3
DK1021183T3 DK98944374T DK98944374T DK1021183T3 DK 1021183 T3 DK1021183 T3 DK 1021183T3 DK 98944374 T DK98944374 T DK 98944374T DK 98944374 T DK98944374 T DK 98944374T DK 1021183 T3 DK1021183 T3 DK 1021183T3
Authority
DK
Denmark
Prior art keywords
antagonist
selective
combination
partial
partial antagonist
Prior art date
Application number
DK98944374T
Other languages
English (en)
Inventor
Stefan Berg
Svante Ross
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1021183T3 publication Critical patent/DK1021183T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98944374T 1997-09-18 1998-09-09 En kombination af en selektiv 5-HT 1A-antagonist og en selektiv h5-HT 1B-antagonist eller partiel antagonist DK1021183T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703374A SE9703374D0 (sv) 1997-09-18 1997-09-18 A new combination

Publications (1)

Publication Number Publication Date
DK1021183T3 true DK1021183T3 (da) 2004-07-05

Family

ID=20408294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944374T DK1021183T3 (da) 1997-09-18 1998-09-09 En kombination af en selektiv 5-HT 1A-antagonist og en selektiv h5-HT 1B-antagonist eller partiel antagonist

Country Status (30)

Country Link
US (1) US6159972A (da)
EP (1) EP1021183B1 (da)
JP (1) JP2001516717A (da)
KR (1) KR20010024075A (da)
CN (1) CN1182847C (da)
AR (1) AR015447A1 (da)
AT (1) ATE261728T1 (da)
AU (1) AU752718B2 (da)
BR (1) BR9812234A (da)
CA (1) CA2302383A1 (da)
DE (1) DE69822490T2 (da)
DK (1) DK1021183T3 (da)
EE (1) EE04142B1 (da)
ES (1) ES2216307T3 (da)
HK (1) HK1032740A1 (da)
HU (1) HUP0100401A3 (da)
IL (1) IL134774A0 (da)
IS (1) IS5408A (da)
MY (1) MY116281A (da)
NO (1) NO20001398L (da)
NZ (1) NZ503174A (da)
PL (1) PL339370A1 (da)
PT (1) PT1021183E (da)
RU (1) RU2215528C2 (da)
SE (1) SE9703374D0 (da)
SK (1) SK2842000A3 (da)
TR (1) TR200000734T2 (da)
TW (1) TW568786B (da)
WO (1) WO1999013876A1 (da)
ZA (1) ZA987810B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (en) * 2001-02-21 2002-08-29 Sankyo Company, Limited Chromene derivatives
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
USD969017S1 (en) 2021-06-28 2022-11-08 Koninklijke Asscher Diamant Maatschappij B.V. Rose marquise diamond article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
FI961247A0 (fi) * 1996-03-18 1996-03-18 Finnish Peroxides Ab Oy Foerfarande foer loesning av uppsvaellningsproblem i en avfalls vattenreningsanordning foer kontroll av traodartiga bakterier
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
TR200000734T2 (tr) 2000-11-21
SE9703374D0 (sv) 1997-09-18
MY116281A (en) 2003-12-31
DE69822490D1 (de) 2004-04-22
HK1032740A1 (en) 2001-08-03
AR015447A1 (es) 2001-05-02
BR9812234A (pt) 2000-07-18
ES2216307T3 (es) 2004-10-16
HUP0100401A3 (en) 2003-01-28
EP1021183A1 (en) 2000-07-26
NO20001398D0 (no) 2000-03-17
PT1021183E (pt) 2004-07-30
CN1182847C (zh) 2005-01-05
AU752718B2 (en) 2002-09-26
EE04142B1 (et) 2003-10-15
TW568786B (en) 2004-01-01
WO1999013876A1 (en) 1999-03-25
IL134774A0 (en) 2001-04-30
JP2001516717A (ja) 2001-10-02
EE200000143A (et) 2001-02-15
ATE261728T1 (de) 2004-04-15
EP1021183B1 (en) 2004-03-17
PL339370A1 (en) 2000-12-18
IS5408A (is) 2000-03-15
NO20001398L (no) 2000-04-04
NZ503174A (en) 2002-03-01
DE69822490T2 (de) 2005-03-03
RU2215528C2 (ru) 2003-11-10
CN1279609A (zh) 2001-01-10
ZA987810B (en) 1999-02-18
HUP0100401A2 (hu) 2002-01-28
US6159972A (en) 2000-12-12
AU9192998A (en) 1999-04-05
SK2842000A3 (en) 2000-09-12
KR20010024075A (ko) 2001-03-26
CA2302383A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
NO972983D0 (no) Sulfonamider og deres anvendelse
NO995784D0 (no) Fytosterol og/eller fytosterolderivater
NO992905L (no) Borings- og/eller kjerneboringsverktöy
DE29615920U1 (de) Gelenkendoprothese
NO964583D0 (no) Lettvekts brönnsementsammensetninger og fremgangsmåter
DE69819567D1 (de) Orthopädische Schnittführung und Hülse
ID22164A (id) Elemen-elemen bangunan
DE69721828D1 (de) Gelenkprothese
DE69732349D1 (de) Expandierbarer stent
DE69731514D1 (de) Expandierbarer Stent
DE69827727D1 (de) Schlagfeste hohle Schaufel
DE59806406D1 (de) Gelenk-Prothesenimplantat
DE69933724D1 (de) Synchronisationsverfahren und Netzwerkbrücke
DK21995A (da) Forbinding og fremgangsmade til fremstilling af forbinding
DK1014985T3 (da) Kombination af en 5-HT-genoptagelsesinhibitor og en h5-HT1B-antagonist eller delvis agonist
DK1068238T3 (da) Integrinheterodimer og subunit deraf
DK0876573T3 (da) Keramisk tænder og fremgangsmåde til anvendelse af samme
DE59708928D1 (de) Gelenkprothese
NO980987D0 (no) Bore- og produksjonsskip
DK1021183T3 (da) En kombination af en selektiv 5-HT 1A-antagonist og en selektiv h5-HT 1B-antagonist eller partiel antagonist
DE29610861U1 (de) Fluchtweg- und Rettungsanordnung
DK0922013T3 (da) Cementerende sammensætninger og anvendelse heraf til cementering af olie- eller tilsvarende brønde
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO940740D0 (no) Ekspandert konstruksjon
DE29616928U1 (de) Baukonstruktion und Verbindungselemente dafür